Clinical trial design webinar

I'd like to invite readers interested in clinical trial design to sign up for our upcoming webinar on the topic. Tufts' Kenneth Kaitin and Neil Patel from PricewaterhouseCoopers will be on hand to discuss some of the latest trends in the field. We've already received some tremendous response for this webinar, with about 500 registered attendees. Don't miss it.

Also, as usual we're taking off July 4th, so we won't be back until Monday. For our readers in the U.S., enjoy the long weekend. For everyone else, we'll be back Monday. - John Carroll

Suggested Articles

Xcovery's ALK inhibitor shrank tumors in 75% of lung cancer patients, compared to 67% for Pfizer's Xalkori, the first FDA-approved drug of that class.

The FDA accepted the regulatory filing for Biogen's once-failed Alzheimer's drug, aducanumab, with plans to decide its fate by March 7, 2021.

Alexion named a chief diversity officer, while COVID-19 vaccine player has two new members of its C-suite.